News

Purdue Pharma L.P. today announced completion of significant oncology related investments as part of its ongoing efforts to diversify its scientific research into areas of high unmet…
Read More...

Syngene International announced that it has expanded its ongoing collaboration with Bristol-Myers Squibb. The next phase of the partnership will see the addition of a new facility to…
Read More...

Ascentage Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for APG-1387, a novel small molecule IAP…
Read More...

Arvinas LLC announced it has expanded its ongoing license agreement with Genentech, a member of the Roche Group, for the development of new therapeutics using Arvinas' novel PROTAC…
Read More...

Evonik is expanding its RESOMER portfolio of bioresorbable polymers for controlled-release parenteral drug formulations. It now offers RESOMER Zero and RESOMER Sterile versions of both…
Read More...

Theravance Biopharma and Mylan announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for revefenacin (TD-4208), an investigational…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for VRAYLAR™ (cariprazine) for the maintenance…
Read More...

Absorption Systems announces the acquisition of TGA Sciences, Inc., a contract R&D laboratory located in Medford, MA, just outside the pharma/biotech hub of Cambridge. TGA Sciences,…
Read More...

Excision BioTherapeutics, a life science company focused on the development and commercialization of advanced gene editing therapeutics for the treatment of life-threatening disease…
Read More...

Avista Pharma Solutions, Inc. has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site. During this expansion, the…
Read More...

Zymeworks announced that it has executed a licensing agreement with Janssen Biotech. The deal was facilitated by Johnson & Johnson Innovation. Under the terms of the licensing…
Read More...

Splunk Inc. announced biotechnology company Recursion Pharmaceuticals is using Splunk® Enterprise and the Splunk Machine Learning Toolkit to reach its goal of treating 100 molecular…
Read More...

Sanofi will develop Principia Biopharma Inc.’s experimental oral treatment that shows promise in multiple sclerosis (MS) and, potentially, other central nervous system (CNS) diseases.…
Read More...

Software and services company Signet Accel announced that Curt Weber joined the company as National Sales Director of its pharma division. With more than two decades in healthcare,…
Read More...

Vetter announced the official opening of a new branch office in South Korea. The new office in Songdo is located within the biologics cluster which is often referred to as a ‘sweet…
Read More...

Ionis Pharmaceuticals and Dynacure announced that Dynacure has licensed IONIS-DNM2-2.5Rx (Dyn101), a Generation 2.5 antisense drug targeting dynamin 2 for the treatment of centronuclear…
Read More...

Innovus Pharmaceuticals announced that it has entered into an agreement with ACON Laboratories. ACON Labs is a San Diego-based diagnostic product manufacturer who will supply Innovus…
Read More...

Alcami announces that it has finalized manufacturing and quality agreements with Solasia Pharma, K.K. (TSE: 4597) for the clinical supply manufacture of the active pharmaceutical…
Read More...

BioMatrix SpRx announced the acquisition of Elwyn Pharmacy Group in Garnet Valley, Pennsylvania, 30 miles southwest of Philadelphia. BioMatrix offers comprehensive nationwide…
Read More...

Spark Therapeutics and Pfizer announced they have entered into an amendment to their license agreement for SPK-9001, an investigational gene therapy for hemophilia B. Spark Therapeutics…
Read More...